The new self-test for detecting the papilloma virus is a game-changer. It’s non-invasive, eliminating the need for a pelvic examination at the gynecologist’s office, and it’s also convenient. Patients can collect their own sample and give it to a clinic nurse, who will then send it to the laboratory for analysis. The laboratory test can detect 14 common strains of the virus, including those that can cause cancer. This new method of testing could increase the rate of women getting tested for the virus, as many cases of cervical cancer occur in women who have never been tested due to embarrassment or difficulty making appointments.
In recent years, there has been a rise in papilloma virus infections globally. It is the most common sexually transmitted disease and affects both men and women. About 30% of women have the virus, and in one-third of cases, it can develop into cancer. Over 200 strains of the virus have been identified to date, with thousands of women in Israel being diagnosed with pre-malignant changes in their cervix every year. The risk of developing warts is increased by smoking as nicotine breakdown products can weaken the immune system. However, many cases do not show any symptoms at all.
The papilloma virus spreads through sexual contact and may appear within three months after infection. While some cases may not show any symptoms at all, others may develop warts or cancer over time if left untreated or undetected early on. Cervical cancer is a serious condition that can be fatal if not caught early enough or treated properly.
Professor Tal Biron believes that this new self-test could help increase testing rates by eliminating barriers such as travel and long wait times at clinics or gynecologists’ offices. Although this self-test is not yet widely available in Israel and only done by gynecologists currently, there are hopes that it will become more accessible soon to increase awareness about this prevalent disease among both men and women alike.
In conclusion, self-testing for papilloma virus should be encouraged because it offers convenience and accessibility while also providing accurate results that can help prevent cervical cancer in its early stages when treatment options are more effective.
